Literature DB >> 19830704

A robust method for comparing two treatments in a confirmatory clinical trial via multivariate time-to-event methods that jointly incorporate information from longitudinal and time-to-event data.

Benjamin R Saville1, Amy H Herring, Gary G Koch.   

Abstract

We consider regulatory clinical trials that require a prespecified method for the comparison of two treatments for chronic diseases (e.g. Chronic Obstructive Pulmonary Disease) in which patients suffer deterioration in a longitudinal process until death occurs. We define a composite endpoint structure that encompasses both the longitudinal data for deterioration and the time-to-event data for death, and use multivariate time-to-event methods to assess treatment differences on both data structures simultaneously, without a need for parametric assumptions or modeling. Our method is straightforward to implement, and simulations show that the method has robust power in situations in which incomplete data could lead to lower than expected power for either the longitudinal or survival data. We illustrate the method on data from a study of chronic lung disease.

Entities:  

Mesh:

Year:  2010        PMID: 19830704      PMCID: PMC3146347          DOI: 10.1002/sim.3740

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  22 in total

1.  Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint.

Authors:  L A Moyé; B R Davis; C M Hawkins
Journal:  Stat Med       Date:  1992-09-30       Impact factor: 2.373

2.  Using trajectories from a bivariate growth curve as predictors in a Cox regression model.

Authors:  Qianyu Dang; Sati Mazumdar; Stewart J Anderson; Patricia R Houck; Charles F Reynolds
Journal:  Stat Med       Date:  2007-02-20       Impact factor: 2.373

Review 3.  Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation.

Authors:  S J Pocock
Journal:  Control Clin Trials       Date:  1997-12

4.  Model-based approaches to analysing incomplete longitudinal and failure time data.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

5.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

6.  The analysis of multiple endpoints in clinical trials.

Authors:  S J Pocock; N L Geller; A A Tsiatis
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

7.  On the design and analysis of randomized clinical trials with multiple endpoints.

Authors:  D I Tang; N L Geller; S J Pocock
Journal:  Biometrics       Date:  1993-03       Impact factor: 2.571

8.  Regression analysis of multivariate grouped survival data.

Authors:  S W Guo; D Y Lin
Journal:  Biometrics       Date:  1994-09       Impact factor: 2.571

9.  Procedures for comparing samples with multiple endpoints.

Authors:  P C O'Brien
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

10.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

View more
  5 in total

1.  Effects of Coping Skills Training on Quality of Life, Disease Biomarkers, and Clinical Outcomes in Patients With Heart Failure: A Randomized Clinical Trial.

Authors:  Andrew Sherwood; James A Blumenthal; Gary G Koch; Benson M Hoffman; Lana L Watkins; Patrick J Smith; Christopher M O'Connor; Kirkwood F Adams; Joseph G Rogers; Carla Sueta; Patricia P Chang; Kristy S Johnson; Jeanne Schwartz; Alan L Hinderliter
Journal:  Circ Heart Fail       Date:  2017-01       Impact factor: 8.790

2.  Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.

Authors:  Emmanuelle Deslandes; Sylvie Chevret
Journal:  BMC Med Res Methodol       Date:  2010-07-29       Impact factor: 4.615

3.  Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Authors:  Gad Cotter; Beth A Davison; Javed Butler; Sean P Collins; Justin A Ezekowitz; G Michael Felker; Gerasimos Filippatos; Phillip D Levy; Marco Metra; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Stefanie Senger; David Bharucha; Kathleen Goin; David G Soergel; Peter S Pang
Journal:  Clin Res Cardiol       Date:  2017-10-06       Impact factor: 5.460

4.  Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

Authors:  Peter S Pang; Javed Butler; Sean P Collins; Gad Cotter; Beth A Davison; Justin A Ezekowitz; Gerasimos Filippatos; Phillip D Levy; Marco Metra; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; David Bharucha; Kathleen Goin; David G Soergel; G Michael Felker
Journal:  Eur Heart J       Date:  2017-08-07       Impact factor: 29.983

5.  Remote Therapy to Improve Outcomes in Lung Transplant Recipients: Design of the INSPIRE-III Randomized Clinical Trial.

Authors:  James A Blumenthal; Patrick J Smith; Andrew Sherwood; Stephanie Mabe; Laurie Snyder; Courtney Frankel; Daphne C McKee; Natalie Hamilton; Francis J Keefe; Sheila Shearer; Jeanne Schwartz; Scott Palmer
Journal:  Transplant Direct       Date:  2020-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.